DE3485128D1 - Zellinien verwendbar zur herstellung von hybridomazellen. - Google Patents

Zellinien verwendbar zur herstellung von hybridomazellen.

Info

Publication number
DE3485128D1
DE3485128D1 DE8484100548T DE3485128T DE3485128D1 DE 3485128 D1 DE3485128 D1 DE 3485128D1 DE 8484100548 T DE8484100548 T DE 8484100548T DE 3485128 T DE3485128 T DE 3485128T DE 3485128 D1 DE3485128 D1 DE 3485128D1
Authority
DE
Germany
Prior art keywords
production
cell lines
hybridoma cells
lines applicable
applicable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8484100548T
Other languages
English (en)
Inventor
Toshihiro Nakanishi
Masashi Matsui
Kenju Matsunokichodanchi Miura
Yoshiaki Fukuda
Teruhisa Noguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP58007745A external-priority patent/JPH0679553B2/ja
Priority claimed from JP58007744A external-priority patent/JPS59132885A/ja
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE3485128D1 publication Critical patent/DE3485128D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C12N5/163—Animal cells one of the fusion partners being a B or a T lymphocyte
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8484100548T 1983-01-20 1984-01-19 Zellinien verwendbar zur herstellung von hybridomazellen. Expired - Lifetime DE3485128D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP58007745A JPH0679553B2 (ja) 1983-01-20 1983-01-20 新規な雑種細胞
JP58007744A JPS59132885A (ja) 1983-01-20 1983-01-20 新規細胞ライン

Publications (1)

Publication Number Publication Date
DE3485128D1 true DE3485128D1 (de) 1991-11-07

Family

ID=26342092

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8484100548T Expired - Lifetime DE3485128D1 (de) 1983-01-20 1984-01-19 Zellinien verwendbar zur herstellung von hybridomazellen.

Country Status (12)

Country Link
US (1) US5126253A (de)
EP (1) EP0114670B1 (de)
KR (1) KR930005453B1 (de)
AU (1) AU569002B2 (de)
CA (1) CA1214123A (de)
CH (1) CH683526A5 (de)
DE (1) DE3485128D1 (de)
DK (1) DK23384A (de)
FR (1) FR2539759B1 (de)
GB (1) GB2134134B (de)
HU (1) HU191984B (de)
IL (1) IL70686A (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies
EP0185135A3 (de) * 1984-12-20 1988-07-13 Suntory Limited Monoklonaler Antikörper
US5126262A (en) * 1984-12-20 1992-06-30 Suntory Limited Monoclonal antibody
US5106746A (en) * 1985-05-22 1992-04-21 E. I. Du Pont De Nemours And Company Process for the in vitro immunization of human splenocytes against tumor associated antigens
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
DE19634159C1 (de) * 1996-08-23 1997-09-25 Gsf Forschungszentrum Umwelt Induktion einer Tumorimmunität durch Injektion von Hybridzellen
ATE317269T1 (de) * 1997-11-10 2006-02-15 Cytimmune Sciences Inc Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
AU2004311630A1 (en) 2003-12-02 2005-07-21 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
CA2554755A1 (en) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
EP2200932A4 (de) * 2007-09-21 2014-09-10 Cytimmune Sciences Inc Nanotherapeutische kolloidale metallzusammensetzungen und verfahren
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
CA2706700A1 (en) 2007-11-08 2009-05-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
DE2757169A1 (de) * 1977-12-22 1979-07-05 Hoechst Ag Verfahren zur gewinnung insulin produzierender tierischer zellen
NZ198851A (en) * 1980-11-07 1984-07-31 Wistar Inst Stable,continuous human myeloma cell line capable of hybridisation with antibody-producing cells:production of hybrid cell line
DE57107T1 (de) * 1981-01-28 1983-04-14 Coats Patons Plc, Glasgow, Scotland Verfahren zur herstellung von monoklonalen antikoerpern und zellen, faehig diese antikoerper herzustellen.
US4434230A (en) * 1981-08-12 1984-02-28 Research Corporation Human nonsecretory plasmacytoid cell line
JPS6011889B2 (ja) * 1981-10-28 1985-03-28 電気化学工業株式会社 継代可能なリンホカイン産生ヒトｔ細胞融合株及びその取得方法
GB2115005B (en) * 1981-12-03 1984-11-14 Cancer Research Campaign Anti rat liver monoclonal antibody
ES8504461A1 (es) * 1982-04-12 1985-04-16 Hybritech Inc Un procedimiento para obtener un polidoma.
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
US4693975A (en) * 1984-11-20 1987-09-15 The Wistar Institute Human hybridroma fusion partner for production of human monoclonal antibodies

Also Published As

Publication number Publication date
KR840007256A (ko) 1984-12-06
DK23384A (da) 1984-07-21
CH683526A5 (de) 1994-03-31
AU2351084A (en) 1984-07-26
US5126253A (en) 1992-06-30
IL70686A0 (en) 1984-04-30
HU191984B (en) 1987-04-28
EP0114670B1 (de) 1991-10-02
FR2539759B1 (fr) 1988-03-25
AU569002B2 (en) 1988-01-14
IL70686A (en) 1988-07-31
GB2134134A (en) 1984-08-08
EP0114670A2 (de) 1984-08-01
GB2134134B (en) 1986-06-18
FR2539759A1 (fr) 1984-07-27
GB8401151D0 (en) 1984-02-22
KR930005453B1 (ko) 1993-06-22
CA1214123A (en) 1986-11-18
DK23384D0 (da) 1984-01-19
EP0114670A3 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
DE3587868D1 (de) Verfahren zur Herstellung von Aerogelen.
DE3587035D1 (de) Wasserundurchlaessige, aber wasserdampfdurchlaessige folie und verfahren zu ihrer herstellung.
ATE102181T1 (de) Zwischenprodukte zur herstellung von 1,2,4triazolo(1,5-a>pyrimidin-2-sulfonamiden.
DE3381755D1 (de) Verfahren zur herstellung von diffraktionsgittern.
DE3583484D1 (de) Verfahren und zellinie zur kontinuierlichen herstellung von mit aids verwandten retrovieren (htlv-iii).
DE3280310D1 (de) Herstellung von polypeptiden in wirbeltierzellkulturen.
IT8424069A0 (it) Processo per la produzione di pellicole porose.
DE3485128D1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
ATE18566T1 (de) Heterogene copolymeren des aethylens zur herstellung von filmen.
DE3481568D1 (de) Herstellung von photodioden.
ATA54881A (de) Kettengewirkte rohware zur herstellung von hoeschen
NO157826C (no) Elektrolysecelle.
ATE38211T1 (de) Herstellung von zeolith-l.
DE3382074D1 (de) Herstellung von hydroxyarylaldehyden.
DE3381907D1 (de) Herstellung von trifluormethylpyridinen.
DE3581238D1 (de) Mikrobiologische herstellung von l-phenylalanin.
ATE11521T1 (de) Verfahren zur herstellung von cyanwasserstoff.
ATA852478A (de) Rohrelemente zur herstellung von rohrsystemen
DE3582003D1 (de) Herstellung von glycolmonoestern.
AT373303B (de) Verfahren zur herstellung von zellstoffen mit niedrigem ligningehalt
DE3780855D1 (de) Zellkultur-methode.
ATE68012T1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
DE68918229D1 (de) Parentale Zellinien für die Herstellung von humanen Hybridomas.
DE3579392D1 (de) Verfahren zur mikrobiologischen herstellung von aldose-1-epimerase.
DE3575556D1 (de) Verfahren zur herstellung von 2-phenylbenztriazolen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee